Literature DB >> 18236437

Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/electrospray ionisation tandem mass spectrometry.

Michael Bredehöft1, Wilhelm Schänzer, Mario Thevis.   

Abstract

Human insulin-like growth factor-1 (IGF-1) is a peptide hormone that acts as a mediator of most of the somatotropic effects of growth hormone (GH). Therefore, it is supposed to be a biomarker indicating GH abuse in sports as well as diseases associated with a change in IGF-1 plasma concentration. It can be applied locally by injection to increase total protein and DNA content in tissues such as skeletal muscle--a highly desirable effect in various sports disciplines. In order to improve its growth-promoting properties, the primary structure of IGF-1 has been modified, yielding analogues such as des(1-3)IGF-1 and LONGR3IGF-1, which show a considerably reduced affinity to the respective binding proteins in plasma and, thus, an increased bioavailability at target tissues. Due to their capability to enhance performance, IGF-1 and its analogues belong to the prohibited list of the World Anti-Doping Agency. Hence, it was necessary to develop a reliable assay for the quantification of human IGF-1 as well as the detection of its derivatives. Immunoaffinity isolation and purification from 60 microL of plasma followed by liquid chromatography/electrospray ionisation tandem mass spectrometry enabled the unequivocal determination of all target analytes. Diagnostic product ions were characterised utilising an Orbitrap mass spectrometer with high resolution/high accuracy properties and employed for triple quadrupole MS/MS analysis. The described assay provided lower limits of detection (LLODs) between 20 and 50 ng/mL, recovery rates between 34-43% and a precision <15% at the LLOD as well as higher concentration levels. In order to prove the applicability of the developed assay, human plasma samples were analysed and the results were compared with the values obtained from a commercially available immunoradiometric assay (IRMA). Four of six samples resulted in concentration ratios with good correlation between both assays, whereas the absolute concentrations were lower for the presented procedure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18236437     DOI: 10.1002/rcm.3388

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  10 in total

Review 1.  Motivations and methods for analyzing pulsatile hormone secretion.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Steven M Pincus
Journal:  Endocr Rev       Date:  2008-10-21       Impact factor: 19.871

2.  Correlation of Insulin-Like Growth Factor-I and -II Concentrations at Birth Measured by Mass Spectrometry and Growth from Birth to Two Months.

Authors:  Colin P Hawkes; Deirdre M Murray; Louise C Kenny; Mairead Kiely; Jonathan O'B Hourihane; Alan D Irvine; Zengru Wu; Yair Argon; Richard E Reitz; Michael J McPhaul; Adda Grimberg
Journal:  Horm Res Paediatr       Date:  2018-01-18       Impact factor: 2.852

Review 3.  Bioanalytical chemistry of cytokines--a review.

Authors:  Julie A Stenken; Andreas J Poschenrieder
Journal:  Anal Chim Acta       Date:  2014-10-12       Impact factor: 6.558

4.  Quantitation of endogenous GnRH by validated nano-HPLC-HRMS method: a pilot study on ewe plasma.

Authors:  Federica Dal Bello; Claudio Medana; Enrica Mecarelli; Riccardo Aigotti; Alberto Asteggiano; Paolo Giacobini; Manon Chasles; Yves Tillet
Journal:  Anal Bioanal Chem       Date:  2022-09-05       Impact factor: 4.478

5.  Quantitative and Selective Analysis of Feline Growth Related Proteins Using Parallel Reaction Monitoring High Resolution Mass Spectrometry.

Authors:  Mårten Sundberg; Emma M Strage; Jonas Bergquist; Bodil S Holst; Margareta Ramström
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

6.  Serum Insulin-like Growth Factor I Quantitation by Mass Spectrometry: Insights for Protein Quantitation with this Technology.

Authors:  Richard Kin Ting Kam; Chung Shun Ho; Michael Ho Ming Chan
Journal:  EJIFCC       Date:  2016-12-01

Review 7.  Advances in Proteomic Techniques for Cytokine Analysis: Focus on Melanoma Research.

Authors:  Helena Kupcova Skalnikova; Jana Cizkova; Jakub Cervenka; Petr Vodicka
Journal:  Int J Mol Sci       Date:  2017-12-13       Impact factor: 5.923

8.  Assuring Consistent Performance of an Insulin-Like Growth Factor 1 MALDImmunoassay by Monitoring Measurement Quality Indicators.

Authors:  Frank Klont; Nick H T Ten Hacken; Péter Horvatovich; Stephan J L Bakker; Rainer Bischoff
Journal:  Anal Chem       Date:  2017-05-10       Impact factor: 6.986

9.  An antibody-free LC-MS/MS method for the quantification of intact insulin-like growth factors 1 and 2 in human plasma.

Authors:  Mark S Pratt; Martijn van Faassen; Noah Remmelts; Rainer Bischoff; Ido P Kema
Journal:  Anal Bioanal Chem       Date:  2021-02-10       Impact factor: 4.142

10.  Targeted selected reaction monitoring mass spectrometric immunoassay for insulin-like growth factor 1.

Authors:  Eric E Niederkofler; David A Phillips; Bryan Krastins; Vathany Kulasingam; Urban A Kiernan; Kemmons A Tubbs; Scott M Peterman; Amol Prakash; Eleftherios P Diamandis; Mary F Lopez; Dobrin Nedelkov
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.